MedTrace Logo

BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease

NCT02655887 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 170

Last updated 2021-02-04

Study results available
· View outcomes & findings →

Summary

The BARD® Venovo™ Venous Stent Study is a non-randomized clinical study intended to collect confirmatory evidence of the safety and effectiveness of the Venous Stent for the treatment of iliofemoral occlusive disease.

Conditions

  • May-Thurner Syndrome
  • Peripheral Vascular Disease
  • Venous Disease
  • Iliofemoral Occlusive Disease

Interventions

DEVICE

VENOVO™ Venous Stent

VENOVO™ Venous stent placement

Sponsors & Collaborators

  • C. R. Bard

    lead INDUSTRY

Principal Investigators

  • Michael Dake, MD · Lead Principal Investigator

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-15
Primary Completion
2018-06-19
Completion
2020-10-30
FDA Device
Yes

Countries

  • United States
  • Australia
  • Germany
  • Ireland
  • Netherlands
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02655887 on ClinicalTrials.gov